Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesA 6-Month, Multicenter, Single-Arm Pilot Study to Evaluate the Efficacy and Safety of Generic Tacrolimus (TacroBell) After Primary Renal Transplantation
Transplantation Proceedings, 07/02/09
Kim SJ et al. - Tacrolimus has been shown to be an important immunosuppressive agent in organ and bone marrow transplantation. Treatment with TacroBell is considered to be efficient and safe after primary renal transplantation.
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Interventions for HIV-associated nephropathy
Cochrane Reviews, 10/19/09
Drug dosage protocol for calcium oxalate stone
Urological Research - Urolithiasis, 10/23/09
Comparison of Gentamicin and Mupirocin in the Prevention of Exit-Site Infection and Peritonitis in Peritoneal Dialysis
Advances in Peritoneal Dialysis, 10/20/09
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Significance and Management of Proteinuria in Kidney Transplant Recipients
Journal of the American Society of Nephrology, 10/12/09
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
Kidney International, 10/27/09
Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients
Rheumatology International, 11/04/09
Article Search
Sponsor